DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
3.960
+0.210 (5.60%)
At close: Apr 2, 2025, 4:00 PM
4.020
+0.060 (1.52%)
After-hours: Apr 2, 2025, 6:23 PM EDT

DiaMedica Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-24.44-19.38-13.68-13.59-12.29
Upgrade
Depreciation & Amortization
0.040.030.030.020.02
Upgrade
Loss (Gain) From Sale of Investments
-1.34-1.22-0.010.16-0
Upgrade
Stock-Based Compensation
2.091.681.51.561.84
Upgrade
Other Operating Activities
0.080.070.060.060.05
Upgrade
Change in Accounts Receivable
0.13-0.290.050.210.48
Upgrade
Change in Accounts Payable
0.010.190.23-0.590.92
Upgrade
Change in Other Net Operating Assets
1.370.190.31-0.08-0.21
Upgrade
Operating Cash Flow
-22.08-18.73-11.51-12.25-9.19
Upgrade
Capital Expenditures
-0.03-0.02-0.08-0.02-0.05
Upgrade
Sale of Property, Plant & Equipment
---00.02
Upgrade
Investment in Securities
8.59-18.2811.62-20.52-16.1
Upgrade
Investing Cash Flow
8.56-18.311.54-20.54-16.13
Upgrade
Long-Term Debt Repaid
-0.01-0.01-0.01-0.01-0.01
Upgrade
Net Debt Issued (Repaid)
-0.01-0.01-0.01-0.01-0.01
Upgrade
Issuance of Common Stock
1236.85-30.2428.85
Upgrade
Other Financing Activities
----0.15-
Upgrade
Financing Cash Flow
11.9936.84-0.0130.0928.85
Upgrade
Net Cash Flow
-1.52-0.190.02-2.73.53
Upgrade
Free Cash Flow
-22.1-18.75-11.59-12.27-9.23
Upgrade
Free Cash Flow Per Share
-0.55-0.58-0.44-0.59-0.59
Upgrade
Cash Income Tax Paid
0.030.030.030.030.04
Upgrade
Levered Free Cash Flow
-11.68-11.45-6.69-7.37-4.87
Upgrade
Unlevered Free Cash Flow
-11.68-11.45-6.69-7.37-4.87
Upgrade
Change in Net Working Capital
-2.9-0.16-0.620.4-1.25
Upgrade
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q